Your browser doesn't support javascript.
loading
Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease.
Khare, Shilpi; Roach, Steven L; Barnes, S Whitney; Hoepfner, Dominic; Walker, John R; Chatterjee, Arnab K; Neitz, R Jeffrey; Arkin, Michelle R; McNamara, Case W; Ballard, Jaime; Lai, Yin; Fu, Yue; Molteni, Valentina; Yeh, Vince; McKerrow, James H; Glynne, Richard J; Supek, Frantisek.
Afiliación
  • Khare S; Department of Genetics and Neglected Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
  • Roach SL; Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
  • Barnes SW; Department of Genetics and Neglected Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
  • Hoepfner D; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
  • Walker JR; Department of Genetics and Neglected Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
  • Chatterjee AK; Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
  • Neitz RJ; Small Molecule Discovery Center and Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America.
  • Arkin MR; Small Molecule Discovery Center and Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America.
  • McNamara CW; Department of Genetics and Neglected Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
  • Ballard J; Department of Genetics and Neglected Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
  • Lai Y; Department of Genetics and Neglected Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
  • Fu Y; Department of Genetics and Neglected Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
  • Molteni V; Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
  • Yeh V; Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
  • McKerrow JH; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, United States of America.
  • Glynne RJ; Department of Genetics and Neglected Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
  • Supek F; Department of Genetics and Neglected Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
PLoS Pathog ; 11(7): e1005058, 2015 Jul.
Article en En | MEDLINE | ID: mdl-26186534
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trypanosoma cruzi / Enfermedad de Chagas / Citocromos b / Antifúngicos Límite: Animals Idioma: En Revista: PLoS Pathog Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trypanosoma cruzi / Enfermedad de Chagas / Citocromos b / Antifúngicos Límite: Animals Idioma: En Revista: PLoS Pathog Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos